The largest mucosal surface in the body is in the gastrointestinal tract, a location that is heavily colonized by microbes that are normally harmless. A key mechanism required for maintaining a homeostatic balance between this microbial burden and the lymphocytes that densely populate the gastrointestinal tract is the production and transepithelial transport of poly-reactive IgA (ref. 1) . Within the mucosal tissues, B cells respond to cytokines, sometimes in the absence of T-cell help, undergo class switch recombination of their immunoglobulin receptor to IgA, and differentiate to become plasma cells 2 . However, IgA-secreting plasma cells probably have additional attributes that are needed for coping with the tremendous bacterial load in the gastrointestinal tract. Here we report that mouse IgA 1 plasma cells also produce the antimicrobial mediators tumour-necrosis factor-a (TNF-a) and inducible nitric oxide synthase (iNOS), and express many molecules that are commonly associated with monocyte/granulocytic cell types. The development of iNOS-producing IgA 1 plasma cells can be recapitulated in vitro in the presence of gut stroma, and the acquisition of this multifunctional phenotype in vivo and in vitro relies on microbial co-stimulation. Deletion of TNF-a and iNOS in B-lineage cells resulted in a reduction in IgA production, altered diversification of the gut microbiota and poor clearance of a gut-tropic pathogen. These findings reveal a novel adaptation to maintaining homeostasis in the gut, and extend the repertoire of protective responses exhibited by some B-lineage cells.
Most class switch recombination (CSR) to IgA takes place in the Peyer's patches and requires encounters between B cells and cytokinesecreting T cells within germinal centres. However, IgA CSR can also take place outside of Peyer's patches within isolated lymphoid follicles of the lamina propria 2 . Local production of nitric oxide (NO) via the inducible nitric oxide synthase (NOS2 or iNOS) has been shown to be a critical mediator of CSR to IgA within the small intestinal lamina propria of mice 3, 4 . Because lymphotoxin-deficient mice have a significant, unexplained IgA defect 5 , we hypothesized that this could be due to a lack of iNOS in the gut. Indeed, we identified a population of CD11c . The absence of iNOS-expressing cells in lymphotoxin-deficient mice prompted us to ask whether B-lineage cells could influence the expression of iNOS within the gut, as lymphotoxin-deficient mice lack some B-cell subsets in the small intestinal lamina propria 5 . Accordingly, we examined B-cell-deficient mice for evidence of iNOS expression in the gut and found that CD11c lo iNOS 1 cells were absent in JH 2/2 mice, Rag2 2/2 mice and strongly reduced in mMt mice (Fig. 1b , Supplementary Table 1 and Supplementary Fig. 1a ). Because lymphotoxin-deficient mice also lack IgA 1 plasma cells, and iNOS-expressing cells are strongly reduced in B-cell-deficient and lymphotoxin-deficient mice, we examined the possibility that IgA 1 plasma cells may have the capacity to produce iNOS. Indeed, when we gated on iNOS 1 cells, we found that they expressed IgA (Fig. 1a ) and low levels of B220 (not shown), indicating that IgA-producing cells may account for significant iNOS expression within the gut in the steady state. In agreement with this result, we found that purified CD11c lo iNOS 1 cells exhibited evidence of a rearranged V-D-JH4 product ( Supplementary Fig. 1b) .
We next asked what proportion of IgA 1 cells express iNOS. Compared to knockout controls, a subset of IgA 1 plasma cells expresses iNOS and TNF-a, the expression of which has also been described in monocyte-derived cells 6 (see Fig. 1c and Supplementary Table 2 for relative frequencies of each population and Fig. 1e for immunofluorescence microscopy). We further confirmed these observations by performing cytospins on small intestinal laminapropria-derived cells ( Supplementary Figs 2 and 3) . Collectively, these data indicate that gut-resident B-lineage cells contribute towards iNOS and TNF-a expression within the small intestinal lamina propria.
To determine better which B-lineage cells were expressing TNF-a/ iNOS, we examined whether previous expression of activation induced cytidine deaminase (AID), an enzyme that is required for both CSR and somatic hypermutation in B cells 7 , correlated with iNOS and TNFa expression. Using AID-Cre 3 YFP mice 8 , we observed three populations of cells in the small intestinal lamina propria: (1) YFP 9 and low levels of CD11c (Fig. 1d , for CD11c, dendritic cells (grey trace) were used as a comparator). By immunofluorescence microscopy, we found that YFP expression co-localizes with IgA expression as expected ( Supplementary Fig. 4) , and using these AID-YFP tissues we detected the expression of iNOS and TNF-a in some, but not all, YFP 1 cells in the small intestinal lamina propria tissue (Fig. 1f) , and occasional co-expression of both iNOS and TNF-a was observed in YFP 1 cells, consistent with our flow cytometry data ( Fig. 1f ; see boxed insert). Taken together, we have found that a proportion of IgA 1 cells within the small intestinal lamina propria express the antimicrobial mediators TNF-a and iNOS. Although we do not detect significant expression of these molecules in other lamina propria cells (YFP
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2 B cells, YFP 2 populations), it is possible that our detection methods are not sufficiently sensitive to pick up low levels of protein expression of TNF-a and iNOS in these cell types, or that expression of TNF-a and iNOS in these cells is induced during particular microbial encounters, as has been observed in non-mucosal tissues 6 . Notably, not all IgA 1 cells expressed iNOS or TNF-a, or coexpressed both iNOS and TNF-a simultaneously (Fig. 1c, d To recapitulate what we observed in vivo, we assessed whether the acquisition of iNOS expression in IgA 1 cells could be supported by gut-derived support/stromal cells (see Methods where we describe the generation of stromal cell monolayers) compared with a bonemarrow-derived S17 stromal cell line or ex vivo preparations of bone marrow stroma 11 . In the presence of a combination of pro-IgA CSR factors, both bone marrow and gut stroma could support the development of YFP 
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AID-YFP mice. However, only gut stroma, but not S17 or bonemarrow-derived stroma, was able to support the development of iNOS 
IgA
1 cells, as preparations of gut stroma from specific pathogen-free but not germ-free mice supports the development of iNOS 1
1 cells (Fig. 2b) . Furthermore, co-incubation of germ-free gut stroma with faecal matter derived from specific pathogen-free mice restores the development of iNOS (Fig. 2b) . Thus, our in vivo and in vitro results suggest that the gut microenvironment, influenced by the local microbiota, supports the development of multifunctional B cells that express IgA and iNOS.
To examine the functional relevance of TNF-a/iNOS expression in IgA 1 cells, we created TNF-a/iNOS double knockout mice (Tnfa
iNOS 2/2 mice exhibited reduced levels of serum IgA (Fig. 3a) , and this reduction was more marked than what we observed for iNOS 2/2 single knockout mice, which, in agreement with previous findings 4 , also exhibited decreased levels of serum IgA (data not shown). Bone marrow from double knockout mice, in combination with B-cell-deficient JH 2/2 bone marrow, was used to reconstitute B-cell-deficient, lethally irradiated recipients, thus creating mixed bone marrow chimaeras in which B cells are unable to produce TNF-a/iNOS (see Supplementary Fig. 6 ). JH 2/2 plus double knockout mixed chimaeric mice exhibited a normal complement of immune cells in the periphery, although we did note some changes in splenic microarchitecture ( Supplementary Fig. 7 ), in agreement with the effects of B-cell-derived TNF-a on splenic stromal cell biology 12 .
Consistent with a role for TNF-a/iNOS in the regulation of CSR to IgA (ref. 4), JH
2/2 plus double knockout mixed bone marrow chimaeric mice exhibited a significant drop in serum IgA but not IgG1 when compared with two groups of control mixed bone marrow chimaeric mice (double knockout plus wild type and JH 2/2 plus wild type mixed bone marrow chimaeric mice) (Fig. 3a, b) , and this decrease in serum IgA tracked with significant reductions in IgA 1 cells within the lamina propria as quantified by immunofluorescence microscopy (Fig. 3c, d ). Although all mixed bone marrow recipients were generated using the same cohort of recipient mice, we observed changes in the composition of the commensal bacterial community in the small intestine of JH 2/2 plus wild type versus JH 2/2 plus double knockout reconstituted mixed bone marrow chimaeric mice (Fig. 3e) . Focusing on microbial populations that are known to influence immune cell function 13 , we noted that segmented filamentous bacteria were nearly absent from JH 2/2 plus double knockout mixed bone marrow chimaeras in small intestinal tissue (P , 0.05), as well as in small intestinal 'scrapes' enriched for epithelial cells (not shown). In contrast, Clostridium leptum and Bacillus were increased in small intestinal tissue of JH 2/2 plus double knockout mixed chimaeras, and this may possibly account for the reduced frequency of segmented filamentous bacteria. The altered composition of commensal microbiota probably reflects the deficiency in TNF-a/iNOS rather than a reduction in IgA, as mice that are completely IgA-deficient exhibit excessive outgrowth of segmented filamentous bacteria 14 . Therefore, although our data do not eliminate the possibility that complete deletion of TNF-a/iNOS in all monocytes/dendritic cells would have an impact on IgA production, these results show that the expression of TNF-a/iNOS in B-lineage cells is essential for the homeostatic production of IgA and the maintenance of an appropriate representation of different commensal microbes within the small intestine.
We next assessed the impact of TNF-a/iNOS deletion in B cells on clearance of the mouse pathogen Citrobacter rodentium, which colonizes the caecum and large intestine following infection. First, using AID-YFP mice, we found that C. rodentium infection results in a significant accumulation of YFP (Fig. 4a-c) . With these kinetics established, we infected JH 2/2 plus wild type versus JH 2/2 plus double knockout mixed bone marrow chimaeras with C. rodentium. Interestingly, C. 1 plasma cells requires microbial exposure. a, Sections of small intestines of germ-free mice and germfree mice that were re-colonized with either a defined altered Schaedler flora (ASF) or reversibly re-colonized with HA107 E. coli by continual gavage administration for 14 days followed by 14 days without gavage returning them to a germ-free status 10 . All sections were stained with specific fluorochrome-tagged antibodies for IgA (green), iNOS (red) and EpCAM (blue) and analysed by fluorescence microscopy. Representative pictures are shown from 6 mice per group. b, B220
1 bone marrow cells from CD45.1 1 wild-type mice were cocultured for 7 days with CD45.2 1 intestinal lamina propria cells (referred to as gut stroma) from either specific pathogen-free or germ-free animals in the presence of IL-7, TGF-b, IL-21 and anti-CD40 antibody. In some cases faecal matter (intestinal wash) was added on the first day of the culture. The expression of IgA and iNOS was analysed by flow cytometry, and the black boxes indicate cells that are iNOS 
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rodentium translocation to the spleen, enhanced weight loss and colonic pathology were all noted in JH 2/2 plus double knockout but not JH 2/2 plus wild type mixed chimaeric mice (Fig. 4d-f) . Similar impaired clearance of C. rodentium was observed in JH 2/2 plus double knockout mixed bone marrow chimaeric mice when they were directly compared with another control group (wild type plus double knockout mixed bone marrow chimaeras; see Supplementary Fig. 8a-c) . Because we did not observe an accumulation of IgA 2 B cells at the site of infection, by inference we conclude that along with other dendriticcell-mediated immune mechanisms, TNF-a/iNOS production by Caecum/large intestine RRag 2/2 mixed chimaeras after C. rodentium infection over time is depicted. Significantly increased body weight loss was observed in double knockout mice from day 6 to 9 after infection (n 5 5-12 per group). Note that double knockout plus JH 2/2 mixed chimaeric mice were killed 9 days after infection for humane reasons as weight loss exceeded 20% of their original body weight. Mean and s.e.m. values are shown. f, Large intestines from wild-type plus JH 2/2 and double knockout plus JH 2/2 mixed chimaeric mice were harvested 9 days after infection and the pathological scores were analysed by standard histological staining procedures using haematoxylin and eosin. Large intestines from double knockout plus JH 2/2 mice show more severe large intestine pathology. Haematoxylin and eosin stainings of two representative double knockout mice with a moderate and a more severe condition, as well as one representative wild-type plus JH 2/2 chimaeric mouse, are shown (n 5 5 mice per group). The panel shows the original magnification of 3100. Scale bars represent 100 mm. *P , 0.05. 1 plasma cells and CD8a 1 cells were quantified from immunofluorescence microscopy images using ImageJ. A total of five different sections from 6 mice (n 5 6) per group was analysed. d, Representative images of frozen small intestinal tissue sections derived from the groups described in a-c stained for CD8a (red), IgA (green) and DAPI (blue). A total of five different sections from 6 mice per group were analysed. e, Seven weeks after bone-marrow reconstitution, the small intestines of wildtype and double knockout mixed chimaeras (n 5 4 for each group) were analysed for their commensal bacteria composition by quantitative real-time PCR amplification of 16S rRNA isolated from small intestinal preparations. Coloured pie graphs represent the percentages of the indicated bacteria species. A significant difference in the relative representation of segmented filamentous bacteria (SFB) was observed between wild-type and double knockout mice. Similar results for segmented filamentous bacteria were obtained in small intestinal scrapes of the epithelium (data not shown). Data represent means and s.d. values. ***P 5 0.001, **P 5 0.01, *P , 0.05.
RESEARCH LETTER
IgA 1 plasma cells is required, either directly or indirectly, for optimal control of C. rodentium in the gut, although it cannot be excluded at this stage that TNF-a/iNOS production by other B-lineage cells outside of the gut may have contributed to the observed phenotype. Moreover, we cannot eliminate the possibility that production of TNF-a/iNOS by B-lineage cells may have provoked the expression of TNF-a/iNOS in monocytes/dendritic cells to control the infection. Nevertheless, our findings show that B-cell-associated TNF-a/iNOS production is critical for control of C. rodentium, and this may explain why B-cell-deficient mice, but not IgA 2/2 mice or mice that lack secreted IgM, also fail to control C. rodentium 15 . The immune system responds differently to antigens encountered systemically as opposed to at mucosal surfaces 1 . We postulate that in the process of differentiating to become IgA 1 plasma cells, the gut environment may have imprinted IgA 1 cells with more 'monocytic' potential, a phenomenon that has been previously observed in vitro 16 . Indeed, there is a precedent for B cells to display non-conventional 'monocyte/dendritic cell' functions in other species 17 and in response to TLR ligation 18 , and B cells have emerged as important effector 19 and regulatory cells 20 during innate responses to bacterial infection. Furthermore, B cells and monocytes share common precursors during their development 21, 22 , and plasma cells have been recently shown to possess antigen-presenting capacity 23 . These results document a novel effector mechanism for IgA 1 plasma cells, which seems to arise in the unique environment of the gut, and may be critical to mount effective responses to microbial assault.
METHODS SUMMARY
Mice. Mice were either purchased from commercial vendors or bred in-house at the University of Toronto. Germ-free wild-type mice were re-derived and maintained in the Germ-free Unit at McMaster University or the University of Bern, Switzerland. Germ-free wild-type mice were re-associated with a low-complexity microbiota, by co-housing with gnotobiotic mice that had been associated with the altered Schaedler flora. Reversible colonization experiments were carried out by gavaging germ-free mice with the E. coli K12 triple mutant strain HA107 and subsequently rested germ-free. Cell purification and flow cytometry. Small intestine (free of Peyer's patches) as well as large intestine and the caecum were dissected, washed and epithelial cells were removed. Remaining tissue was digested with collagenase and the resulting suspension was filtered and analysed by flow cytometry or used for cytospin preparations. For flow cytometry, cells were subjected to aqua dead cell stain, then incubated with Fc-block followed by incubation with pre-determined concentrations of fluorochrome labelled antibodies to cell-surface markers, fixed/permeabilized and incubated with pre-determined concentrations of fluorochrome labelled antibodies to intracellular proteins. Cells were acquired using either a FACS Cailbur or a LSR-II (BD Biosciences). Acquired data were analysed and processed using FlowJo. Immunofluorescence microscopy. Re-hydrated 5 mm sections of small intestinal tissue were subjected to blocking with serum and Fc-block followed by staining with fluorochrome-labelled antibodies. Slides were then stained with DAPI before being mounted with Gel/Mount and visualized with a Leica DMRA2 microscope accompanied by OpenLab software (Improvision). Co-culture of stromal cells and bone marrow cells. Bone-marrow-or laminapropria-derived stromal cells were plated together with bone-marrow-derived B220 1 congenically disparate (CD45.1) cells. Co-cultures were supplemented with IgA switch factors including TGF-b, IL-21 and anti-CD40 as well as IL-7. At the indicated times, cells were harvested and analysed by flow cytometry.
METHODS
Mice. Wild-type C57BL/6.CD45.2 mice were obtained from in-house breeding or from commercial vendors. We compared the population of iNOS 1 cells in small intestinal lamina propria preparations from Charles River Laboratories, from Taconic and from Jackson Laboratories and found no significant differences in the frequency of iNOS 1 cells (data not shown). C57BL/6.CD45.1, mMt, Rag2
and CD19-YFP were all purchased from Jackson Laboratories and bred in-house. Tnfa 2/2 and iNOS 2/2 deficient animals were purchased from Taconic and crossed. Ltb 2/2 mice were purchased from B&K Universal. Ltbr 2/2 mice were obtained from R. D. Newberry. AID-YFP 8 was provided by R. Casellas. JH 2/2 mice were obtained from S. Fillatreau. All animals were housed in specific pathogen-free conditions and all experiments were performed according to animal use protocols approved by the animal care committee of the Ontario Cancer Institute and the University of Toronto. Germ-free mice and microbiota re-associations. C57BL/6 mice were re-derived to germ-free by two-cell embryo transfer and were maintained germ-free in flexible film isolators at the Farncombe Axenic and Germ-free Unit of the Central Animal Facility, McMaster University, Canada or in the Clean Animal Facility, University of Bern, Switzerland as previously described 10 . For re-colonization experiments, C57BL/6 mouse colonies were re-associated with a low-complexity microbiota, by co-housing with gnotobiotic mice that had been associated with the altered Schaedler flora (ASF, Taconic) consisting of eight different bacteria 24 , according to the protocol available at Taconic (http://www.taconic.com/library). These mice were used as ASF experimental mice and as sentinel colonizers for ASF reassociations of germ-free animals. Re-associated animals were maintained under barrier conditions in IVC cages in the Farncombe Axenic and Germ-free Unit or in the Clean Animal Facility, University of Bern, Switzerland, as previously described 10 . Reversible colonization experiments were carried out by gavaging germ-free mice four times with the E. coli K12 triple mutant strain HA107 (ref. ) from sex-matched donors. Mice were then provided 2 mg ml 21 neomycin-sulphate (Sigma-Aldrich) supplemented drinking water for 2 weeks after irradiation. Mice were further used for experiments following 8-10 weeks of reconstitution. Bacterial infection. A nalidixic-acid-resistant strain of C. rodentium DBS100 (provided by B. Finlay) was grown overnight at 37 uC with moderate shaking. 1 3 10 9 colony-forming units (c.f.u.) of the overnight culture, which was washed once in PBS, were used to inoculate mice by oral gavage. The mice were fasted for 3 h before challenge. The percentage of body weight loss of animals after infection was monitored. At indicated time points animals were killed and organ colonization by C. rodentium was determined by homogenizing tissues in sterile PBS using a rotor homogenizer followed by serial dilution plating on nalidixic-acid-containing LB plates. For pathological examination of tissues, large intestines were collected, the faecal content removed and washed twice in PBS and opened longitudinally. Tissues were fixed for 2 days in 10% formalin, washed twice with PBS and fixed for 18 h in 70% ethanol. Samples were embedded in paraffin, sectioned and analysed by standard histological staining procedures using haematoxylin and eosin. Immunofluorescence microscopy. Small intestines were cut out and mesentery and fat removed. After gently pushing out the faecal content, small intestines were washed twice in PBS and cut open longitudinally and pieces were frozen in OCT compound (Sakura Finetek). Similarly, spleens from animals were removed and frozen in OCT. Spleens and intestinal tissue sections were cut at 5 mm using a Leica CM3050 cryostat (Leica Microsystems), mounted on glass microscope slides and fixed in acetone. Sections were washed TBS followed by TBS-T (TBS plus 0.05% Tween-20 (Sigma Aldrich)), then incubated with TBS-T supplemented with 10% normal rabbit serum (Jackson Laboratories), 10% normal mouse serum (Jackson Laboratories), 5% BSA (Sigma) and 2 mg ml 21 of a rat anti-mouse CD16/CD32 antibody (Fc-block, clone: 2.4G2) for 30 min to block nonspecific staining. Fluorochrome labelled antibodies were applied for 45 min in the dark. The following antibodies were used: rat anti-mouse IgA-FITC (11-44-2, Southern Biotech), rabbit anti-mouse iNOS-PE (N-20, Santa Cruz Biotechnology), rat anti-mouse CD8a-PE (53-6.7) rat anti-mouse EpCAM-APC (G8.8), rat antimouse TNF-a-APC (MP6-XT22), rabbit anti-mouse TNF-a (610325, R&D) followed by biotinylated anti-rabbit (Molecular probes) and Streptavidin-PE, rat anti-mouse CD21/CD35-biotin (8D9) followed by Streptavidin-Alexa488 (InVitrogen). Except otherwise mentioned, all antibodies were purchased from eBioscience. After removal of the staining solution slides were washed three times with TBS-T, once with TBS and once with PBS. Finally, slides were stained with DAPI nucleic acid stain (InVitrogen) for 30 s and washed three times with PBS before being mounted with Gel/Mount (Biomeda Corp.). Images were acquired with a Leica DMRA2 microscope (Leica Microsystems) equipped with a Retiga EXi digital camera (Q Imaging) using OpenLab software (Improvision) and Adobe Photoshop. Quantification of IgA and CD8a 1 cells was performed using Image J. Isolation of intestinal lamina propria cells. Small and large intestines were cut out and mesentery and fat removed, flushed, Peyer's patches were removed and the intestine was cut open longitudinally and into pieces of ,5 mm. The caecum was opened, the content removed and the tissue cut in pieces. Tissue pieces were washed twice by gentle vortexing for a few seconds in ice-cold buffer (HBSS (Gibco) supplemented with 2% FBS (PAA) and 15 mM HEPES pH 7.4). The epithelial cells and intestinal epithelial lymphocytes were then removed by transferring the gut pieces to an EDTA-containing buffer (HBSS (Gibco) supplemented with 10% FBS (PAA), 5 mM EDTA, 15 mM HEPES, buffered with NaOH at pH 7.4) and shaken vigorously at room temperature for 10 min, vortexed gently for a few seconds, before decanting the supernatant. This wash step was repeated three times. Gut pieces were then washed three times in cold HBBS buffer (Gibco) to remove residual EDTA before transfer into RPMI 1640 supplemented with 10% FBS (PAA), 15 mM HEPES pH 7.4, collagenase type IV (0.25 mg ml 21 , Sigma) and DNase I (0.05 mg ml
21
, Roche) for digestion of tissue for approximately 1-2 h at 37 uC with occasional vortexing. The resulting suspension was filtered through a 70 mm nylon cell strainer to obtain a single cell suspension. Finally cells were washed and resuspended in ice-cold FACS buffer containing PBS supplemented with 2% FBS (PAA) and analysed by flow cytometry or used for cytospin preparations. Isolation of splenocytes. Spleens were collected and fat was removed. Tissue was gently homogenized with glass slides in digestion buffer (HBSS (Gibco) supplemented with 10 mM HEPES, 150 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , 1 mg ml 21 collagenase D (Roche) and 0.2 mg ml 21 DNase I (Roche)) and incubated for 30 min at 37 uC. The cell suspension was homogenized by gentle pipetting before being incubated for an additional 15 min at 37 uC before the addition of EDTA (final concentration 1 mM) and incubation for 10 min at room temperature. Cells were pelleted and re-suspended in red blood cell lysis buffer for 1 min on ice (150 mM NH 4 Cl, 100 mM NaHCO 3 , 1 mM EDTA pH 8.0). Cells were then re-suspended in FACS buffer (PBS supplemented with 2% FBS (PAA)) and pelleted by centrifugation. Finally, cells were filtered through a 70 mm nylon cell strainer and pelleted by centrifugation, re-suspended in FACS buffer (PBS supplemented with 2% FBS (PAA)) and analysed by flow cytometry. Flow cytometry. Cells were washed with ice-cold PBS (no FBS) and before antibody staining a live/dead stain was applied using the fixable aqua dead cell stain kit (InVitrogen). After that, cells were transferred to ice-cold PBS 1 2% FBS (PAA) and incubated with 1 mg ml 21 of a rat anti-mouse CD16/CD32 antibody (Fc-block, clone: 2.4G2) to block unspecific staining for 15 min at 4 uC. Predetermined concentrations of fluorochrome-labelled antibodies were added in a total volume of 100 ml, thoroughly mixed with the cells and incubated for 15 min at 4 uC. The following antibodies were used: murine anti-mouse CD45.1-Pacific Blue (A20), murine anti mouse CD45.2-Pacific blue (104, Biolegend), rat anti-mouse CD11b-FITC (M1/70), rat anti-mouse Ly6C-PerCP-Cy5.5 (HK1.4), rat anti-mouse CD11b-APC (M1/70), hamster anti-mouse CD11c-APC (N418), rat anti-mouse CD11b-PE-Cy7 (M1/70), hamster anti-mouse CD11c-PE-Cy7 (N418), rat anti-mouse CD19-FITC (1D3), rat anti-mouse CD4-PE (GK1.5), rat anti-mouse CD8a-PerCP-Cy5.5 (53-6.7), rat anti-mouse CD45R (B220)-eFluor450 (RA3-6B2), rat anti-mouse Ly6G-PE (1A8, BD Biosciences), and rat anti-mouse CD138-APC (281-2, BD Biosciences). After washing with FACS buffer, cells were fixed and permeabilized using a cytofix/cytoperm kit from BD Biosciences according to the manufacturer's protocol. Intracellular staining was then performed for 30 min at 4 uC using the following antibodies: rat anti-mouse IgA-FITC (11-44-2, Southern Biotech), IgA-PE (11-44-2, Southern Biotech), rat anti-mouse IgA-biotin (11-44-2) followed by Streptavidin-APC-Cy7 or Streptavidin PerCp-Cy5.5, murine anti-mouse iNOS-FITC (6, BD Biosciences), mouse anti-mouse IgG1 iNOS-Alexa647 (C-11, Santa Cruz Biotechnology used fresh at 1/25 and compared with an Alexa647-conjugated mouse anti-mouse IgG1 isotype control), rat anti-mouse TNF-a-PE (MP6-XT22, BD), rat anti-mouse TNFa-APC (MP6-XT22, BD). Except otherwise mentioned, all antibodies have been purchased from eBioscience. Cells were then washed twice with Perm/Wash buffer and re-suspended in FACS buffer before analysis by flow cytometry using either a FACS Cailbur, or Canto II or an LSR-II (BD Biosciences). Acquired data were analysed and processed using FlowJo (Tree Star Inc.). Analysis of VDJ recombination. Intestinal lamina propria cells and splenocytes were isolated and stained with the antibodies as described above. Lamina propria cells and splenocytes were sorted for CD3e 1 or CD19 1 populations. In addition,
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